U.S. Pharma Stock News

NYSE:NVT
NYSE:NVTElectrical

Is It Too Late To Consider nVent Electric (NVT) After Its Powerful Share Price Run?

If you are wondering whether nVent Electric's share price still offers value after a strong run, you are not alone. The stock last closed at US$166.73, with returns of 16.7% over 7 days, 40.2% over 30 days, 56.1% year to date and 176.7% over the past year, while the 3 year return stands at 317.4% and the 5 year return is 473.4%. Recent coverage has focused on nVent Electric in the context of its sector and broader market. This helps frame how investors are thinking about its prospects and...
NYSE:GNRC
NYSE:GNRCElectrical

Is It Too Late To Consider Generac Holdings (GNRC) After Its Powerful Share Price Run?

Wondering whether Generac Holdings at around US$266.75 is still offering value after a strong run, or if you are late to the story? This article focuses squarely on what the current price might imply. The stock has posted returns of 2.9% over 7 days, 39.6% over 30 days, 89.1% year to date, 121.2% over 1 year and 138.3% over 3 years, while the 5 year return sits at a 9.1% decline, a mix that can change how investors think about both upside and risk. Recent news coverage has focused on Generac...
NasdaqGS:VICR
NasdaqGS:VICRElectrical

Is It Too Late To Consider Vicor (VICR) After Its Rapid Share Price Surge?

Wondering if Vicor at around US$261 per share still offers value or if the easy gains are behind it? This article unpacks what the current price might really imply. The stock has seen a 63.5% return over the past 30 days and a 123.6% return year to date, with a very large 1 year return and a 499.7% return over 3 years that naturally raises questions about risk, expectations, and what is already priced in. Recent coverage has focused on Vicor's role in high performance power solutions for...
NYSE:PRIM
NYSE:PRIMConstruction

Primoris Services Faces Earnings Miss Guidance Cut And Legal Uncertainty

Primoris Services (NYSE:PRIM) reported Q1 2026 results with an earnings miss and a sharp cut to full year guidance for earnings per share and EBITDA. The company cited cost overruns and project delays in renewables, especially solar, tied to labor challenges, weather, and less familiar markets. Leadership changes, an adjustment in approach to certain geographies, and a new securities law investigation have added to investor uncertainty. The recent acquisition of PayneCrest is reshaping...
NasdaqGS:FROG
NasdaqGS:FROGSoftware

JFrog’s Q1 Beat Puts AI Growth And Buybacks In Focus

JFrog (NasdaqGS:FROG) reported a strong Q1 2026, with robust revenue growth and faster cloud adoption. The company highlighted new AI driven capabilities across its platform, focused on software supply chain security. Management raised full year guidance and the board authorized a major share repurchase program. JFrog operates at the intersection of software delivery, DevOps, and security, areas that sit at the core of how modern applications are built and maintained. The fresh focus on AI...
NYSE:AXTA
NYSE:AXTAChemicals

Assessing Axalta Coating Systems (AXTA) Valuation After Softer Earnings And Flat Near‑Term Growth Outlook

Axalta Coating Systems (AXTA) shares have been reacting to fresh first quarter results, with sales of US$1,254 million and net income of US$90 million, along with guidance calling for flat second quarter net sales growth. See our latest analysis for Axalta Coating Systems. The first quarter update and cautious outlook appear to be weighing on sentiment, with Axalta Coating Systems’ recent 9.34% 1 month share price return still sitting against a weaker 1 year total shareholder return of...
NYSE:MRP
NYSE:MRPSpecialized REITs

Millrose Properties (MRP) Is Down 12.3% After Surging Q1 Revenue And Net Income Report

Millrose Properties, Inc. has reported past first-quarter 2026 results, with revenue rising to US$194.93 million and net income to US$122.88 million, both significantly higher than the same period a year earlier. The sharp increase in revenue relative to the prior year's US$82.70 million highlights how much more transaction activity Millrose is now channeling through its land banking model. We will now examine how this sharp jump in quarterly revenue and net income affects Millrose...
NasdaqGS:EXC
NasdaqGS:EXCElectric Utilities

Is It Time To Reassess Exelon (EXC) After Recent Share Price Weakness?

Investors may be assessing whether Exelon at around US$44.41 is offering fair value today, or if the current price is mispricing the long term story. The stock has slipped 3.4% over the last 7 days and 9.5% over the last 30 days, while the 1 year return sits at 2.0% and the 5 year return at 65.7%. Recent attention on Exelon has centered on its role as a large regulated utility. Investors are watching how its business mix and capital plans fit into long term energy and grid needs. This...
NasdaqGS:CAI
NasdaqGS:CAIBiotechs

Is It Time To Reconsider Caris Life Sciences (CAI) After 26.5% Year To Date Decline?

If you are trying to work out whether Caris Life Sciences at around US$19.84 is attractively priced or not, you will want a clear view of what that tag really reflects. The stock has recently shown mixed momentum, with a 4.4% return over the last 7 days and 5.8% over the last month, while the year to date return stands at a 26.5% decline. Recent headlines around Caris Life Sciences have focused on its role in precision medicine and diagnostics, alongside ongoing attention to how it funds and...